Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies.
Ryskeldinova S, Zinina N, Kydyrbayev Z, Yespembetov B, Kozhamkulov Y, Inkarbekov D, Assanzhanova N, Mailybayeva A, Bugybayeva D, Sarmykova M, Khairullin B, Tabynov K, Bulashev A, Aitzhanov B, Abeuov K, Sansyzbay A, Yespolov T, Renukaradhya GJ, Olsen S, Oñate A, Tabynov K. Ryskeldinova S, et al. Among authors: assanzhanova n. Front Cell Infect Microbiol. 2021 Jul 1;11:669196. doi: 10.3389/fcimb.2021.669196. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34290993 Free PMC article.
Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A. Tabynov K, et al. Among authors: assanzhanova n. Vaccine. 2014 Apr 11;32(18):2034-41. doi: 10.1016/j.vaccine.2014.02.058. Epub 2014 Mar 2. Vaccine. 2014. PMID: 24598723 Free article.
First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
Tabynov K, Yespembetov B, Matikhan N, Ryskeldinova S, Zinina N, Kydyrbayev Z, Assanzhanova N, Tabynov K, Renukaradhya GJ, Mukhitdinova G, Sansyzbay A. Tabynov K, et al. Among authors: assanzhanova n. Vet Microbiol. 2016 Dec 25;197:15-20. doi: 10.1016/j.vetmic.2016.11.001. Epub 2016 Nov 3. Vet Microbiol. 2016. PMID: 27938677
Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs.
Bugybayeva D, Ryskeldinova S, Zinina N, Sarmykova M, Assanzhanova N, Kydyrbayev Z, Tabynov K. Bugybayeva D, et al. Among authors: assanzhanova n. Biomed Res Int. 2020 Nov 19;2020:1438928. doi: 10.1155/2020/1438928. eCollection 2020. Biomed Res Int. 2020. PMID: 33274194 Free PMC article.
A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
Bugybayeva D, Kydyrbayev Z, Zinina N, Assanzhanova N, Yespembetov B, Kozhamkulov Y, Zakarya K, Ryskeldinova S, Tabynov K. Bugybayeva D, et al. Among authors: assanzhanova n. Infect Dis Poverty. 2021 Feb 16;10(1):13. doi: 10.1186/s40249-021-00801-y. Infect Dis Poverty. 2021. PMID: 33593447 Free PMC article.
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Zhugunissov K, et al. Among authors: assanzhanova n. Front Microbiol. 2021 Sep 27;12:720437. doi: 10.3389/fmicb.2021.720437. eCollection 2021. Front Microbiol. 2021. PMID: 34646246 Free PMC article.
15 results